EU accepts Sanofi commitments in antitrust case, EVP Ribera announces

The European Commission has accepted commitments offered by Sanofi to address antitrust concerns, closing the investigation without fines. The specific commitments and market impact remain unclear, but the decision removes regulatory overhang for Sanofi and signals the Commission's continued use of commitments in pharma cases.